Article
Xenograft and organoid models in developing precision medicine for gastric cancer (Review)
22 Feb 2024
Abstract excerpt
Gastric cancer (GC), a highly heterogeneous disease, has diverse histological and molecular subtypes. For precision medicine, well‑characterized models encompassing the full spectrum of subtypes are necessary. Patient‑derived tumor xenografts and organoids serve as important preclinical models in GC research. The main advantage of these models is the retention of phenotypic and genotypic heterogeneity present in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
